These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6812990)

  • 1. Two automated methods for plasma antithrombin III compared, and the clinical significance of the results.
    Prellwitz W; Schmitt KF; Machner M; Schuster CJ; Weilemann L
    Clin Chem; 1982 Nov; 28(11):2249-53. PubMed ID: 6812990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assay of plasma heparin and heparin-antithrombin III complex--studies in normal volunteers and thromboembolic patients].
    Oguma Y; Hasegawa H; Nagata H; Kawakami Y
    Rinsho Ketsueki; 1986 May; 27(5):723-9. PubMed ID: 3747167
    [No Abstract]   [Full Text] [Related]  

  • 3. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
    Frantzen Handeland G; Abildgaard U; Aasen AO
    Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
    Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
    Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of an automated assay of effective heparin activity in plasma.
    Pierson-Perry JF; Obzansky DM; Mizzer JP
    Clin Chem; 1987 Sep; 33(9):1630-4. PubMed ID: 3621562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].
    Gerhards H
    Tierarztl Prax; 1987; 15(1):47-55. PubMed ID: 3590168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].
    Hesse R; Tritschler W; Castelfranchi G; Bablok W
    Blut; 1981 Apr; 42(4):227-34. PubMed ID: 7225580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
    Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and analytical performance of automated tests for antithrombin III and plasminogen on the Du Pont aca analyzer.
    Perry JF; Siefring GE; Reider MC; Coleman PL; Wehrly JA
    Clin Chem; 1983 Apr; 29(4):609-13. PubMed ID: 6831687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?
    Schmidt BK; Muraji T; Zipursky A
    Eur J Pediatr; 1986 Dec; 145(6):500-3. PubMed ID: 3816852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
    Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
    Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
    Lourenço DM; Noguti MA; Juliano L
    Rev Assoc Med Bras (1992); 1995; 41(6):373-8. PubMed ID: 8733245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects of acquired antithrombin III deficiency].
    von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
    Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased production or increased turnover of antithrombin III in severe acquired coagulopathy?
    Schmidt B; Wais U; Pringsheim W; Witt I; Künzer W
    Klin Wochenschr; 1981 Dec; 59(24):1349-51. PubMed ID: 7321483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of antithrombin III.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):276-87. PubMed ID: 6758119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.